TrialPloS one2025

The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study.

Wongsakorn Luangphiphat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.